Document is current
Any future updates will be listed below
-
Authors
Noto, Shinichi https://orcid.org/0000-0002-6952-7770
Kieffer, Alexia https://orcid.org/0009-0004-5735-195X
Soudani, Samira https://orcid.org/0009-0006-4523-6588
Arashiro, Takeshi
Tadera, Chiho
Eymere, Sebastien https://orcid.org/0000-0001-8074-5480
Lemański, Tobiasz
Wang, Xinyu https://orcid.org/0009-0009-3151-8092
-
Funding
Funding for this research was provided by:
Sanofi K.K.
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 10 March 2025
First Online: 28 March 2025
Declarations
:
: Shinichi Noto had received consultancy fees from Sanofi K.K., Otsuka Pharmaceutical K.K., Nippon Boehringer Ingelheim K.K., CSL Behring K.K., and Bristol-Myers Squibb K.K. Alexia Kieffer, Takeshi Arashiro, Samira Soudani, Chiho Tadera, and Xinyu Wang are employees of Sanofi and may hold shares and/or stock options in the company. Tobiasz Lemański and Sebastien Eymere were employees of Putnam at the time of manuscript redaction. Sebastien Eymere remains an employee of Putnam. Putnam received consulting fee from Sanofi to support the preparation of the analysis. Tobiasz Lemański is now an employee of Clever Access.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
